True Wealth Design’s Neuropace NPCE Stock Holding History

True Wealth Design’s Portfolio NPCE Stock Details NPCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$96	Buy	+6	New	+$97	﹤0.01%	2543
2025 Q3	–	Sell	-10	Closed	-$112	–	2826
2025 Q2	$112	Buy	10 +4	+67%	+$50	﹤0.01%	2214
2025 Q1	$74	Buy	+6	New	+$75	﹤0.01%	2291

Other funds holding NPCE

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

HFS

Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return

True Wealth Design's NPCE Position: Q2 2026 in Review

True Wealth Design opened a new position in Neuropace (NPCE) in Q2 2026: 6 shares worth $96. The stake represents ﹤0.01% of the portfolio and ranks #2543 among its holdings. This is a return to the name: True Wealth Design previously reported a position in NPCE as recently as Q2 2025.

True Wealth Design first reported a position in NPCE in Q1 2025 and has held it in 3 quarters since. The position peaked at $112 in Q2 2025. 4 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

True Wealth Design held 6 shares of Neuropace worth $96 as of Q2 2026.
Neuropace was a new True Wealth Design position in Q2 2026.
Neuropace made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2543 holding.
True Wealth Design first reported a position in Neuropace in Q1 2025 and has held it in 3 quarters since.
True Wealth Design's Neuropace position peaked at $112 in Q2 2025.
4 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.